Cat Allergy Study
Cliantha Research, Clinical Research Organization (CRO)
The purpose of this study is to identify the best dose of test product: Cat hair allergen which causes allergic symptoms (including sneezing, runny nose, congestion/blockage and itchy nose) in a test called Skin Prick Test (SPT). This test will be used to provide an indication of the effectiveness of cat allergy treatments. No medication will be administered in this study.
Eligibility Criteria
Male, Female
18 to 65 years old
Clinical history of cat allergy
Not have a cat at home or will be regularly exposed to cats
Not have a history of anaphylaxis to cat allergen
Not currently undergoing or have undergone cat immunotherapy within the last 12 months
Other inclusion/exclusion criteria applicable and will be assessed
Study Tasks
Informed Consent Document (ICD)
Medical history and demographics
Measurement of vital signs and physical exam
Skin prick test (SPT)
Nasal exam and nasal provocation test
Other tasks will be outlined during the ICD process
COVID-19 testing will be conducted at designated visit
Ethics
This study has been approved by Advarra Ethics Board
Keywords
Activity and Time
Investigational Medicine
Clinical Trial
Weekdays, Weekends
15 hours total, 4 sessions
The study visits include General Screening, Visit 1 Medical Screening, COVID-19 testing Visit, and Visit 2, with Visit 1 and Visit 2 being 2 to 30 days apart. The study duration will be approximately 5-6 weeks.
Compensation
Up to $975
Compensation for General Screening is up to $50, and $925 for study participation upon completion of the study.
Study Address
4500 Dixie Rd Mississauga, Ontario, Canada, L4W 1N2
Earn $975